What are my options? A feasibility study of a personalized primary prevention strategy for women and men at high risk of breast and prostate cancer

Not Applicable

• Conditions: Breast and prostate cancers; Cancer

• Registration Number: ISRCTN15749766
• Lead Sponsor: CHU de Québec-Université Laval

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-05
• Last Update Posted: 18 June 2024
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Breast cancer-free adult women with one or more of the following characteristics :
1. Having a first-degree family history of breast cancer
2. Personal history of breast atypical hyperplasia
3. An extreme breast density
4. Being a mutation carrier in high or moderate penetrance genes.

Prostate cancer-free adult men with one or more of the following characteristics :
1. Being an African-descent origin
2. Being a BCRA1/2 mutation carrier
3. Having an elevated prostate-specific antigen.
4. Having a first-degree family history of prostate cancer.

Exclusion Criteria

1. Personal history of any cancer
2. Participation in a clinical study on primary prevention of breast cancer and prostate cancer
3. Engaged in a decision-making process regarding breast cancer and prostate cancer preventive measures

Study & Design

• Study Type: Interventional
• Study Design: Not specified